Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on May 13, 2025

XRP News: Vaultro Finance Presale Moves Fast — Early Investors Eye Massive 30% Listing Gain on XRP’s Hottest DeFi Protocol
SINGAPORE, May 13, 2025 (GLOBE NEWSWIRE) -- With XRP breaking past $2.50 and reclaiming its position as one of the top three cryptocurrencies by market cap, investor enthusiasm is flooding into the XRP Ledger ecosystem, and one project is stealing the …

PBGH Announces Jumbo Employers’ Top 5 Health Care Priorities
Oakland, California, May 13, 2025 (GLOBE NEWSWIRE) -- Purchaser Business Group on Health (PBGH), a nonprofit coalition representing 40 private employers and public entities across the U.S., announced today the results of its member survey on top health …

Delinea Begins FedRAMP High Authorization Process for Secret Server
SAN FRANCISCO, May 13, 2025 (GLOBE NEWSWIRE) -- Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, has initiated the FedRAMP High authorization process for Secret Server, an industry- …

Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting …

Plotly Honored as Bronze Stevie Award Winner In 2025 American Business Awards
MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- Plotly, the premier Data App platform for Python, has been named a Bronze Stevie® Award winner in the Artificial Intelligence/ Machine Learning Solution – Other category in The 23rd Annual American Business Awards …

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury
DENVER, May 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced …

Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference
CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a …

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results
SOLANA BEACH, Caif., May 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will …

Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway
IND cleared for pan-RAS molecular glue ERAS-0015 and IND submitted for pan-KRAS inhibitor ERAS-4001, both ahead of schedule; Phase 1 monotherapy data for both programs expected in 2026 Meaningful extension of cash runway guidance from H2 2027 to H2 2028 …

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results
Continued Progress in Ongoing Late-Stage Netherton Syndrome Studies Announced Positive Clinical Data for Adult and Pediatric Netherton Patients Provided Clear Visual Evidence of QRX003 Mechanism of Action Patent Portfolio Expanded to Support Pipeline …

Microchip Opens Registration for its 25th Annual MASTERs Conference in Scottsdale, Arizona
CHANDLER, Ariz., May 13, 2025 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP) today announces that registration is now open for its MASTERs Conference in North America, the premier technical training event for embedded design engineers. This year …

Reviva to Participate in the A.G.P. Healthcare Company Showcase
CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the H.C. …

Advanced Technology International Acquires Carrot
SUMMERVILLE, S.C., May 13, 2025 (GLOBE NEWSWIRE) -- We are excited to announce that effective March 31, 2025, Advanced Technology International (ATI), a South Carolina based 501(c)3 public service nonprofit, acquired the assets of The Common Pool, LLC, dba …

red violet to Present at the 25th Annual B. Riley Securities Investor Conference
BOCA RATON, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the 25th Annual B. Riley Securities Investor Conference being held May 21-22 …

ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …

Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic Innovation
OREM, Utah, May 13, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in cryogenic technology, today announced a U.S. Patent for its innovative system to cool computer rooms using cryogenic methods. This development addresses the …

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion leader surgeons in critical geographies during the second …